MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1

被引：0
|
作者：
Jing Liu
Kai-Hua Lu
Zhi-Li Liu
Ming Sun
Wei De
Zhao-Xia Wang
机构：
[1] The Second Affiliated Hospital of Nanjing Medical University,Department of Oncology
[2] Nanjing University,Immunology and Reproductive Biology Lab of Medical School and State Key Laboratory of Pharmaceutical Biotechnology
[3] The First Affiliated Hospital of Nanjing Medical University,Department of Oncology
[4] Nanjing Medical University,Department of Biochemistry and Molecular Biology
来源：
BMC Cancer | / 12卷
关键词：
A549 Cell; NSCLC Patient; NSCLC Cell; NSCLC Tissue; Nontumor Tissue;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1
    Liu, Jing
    Lu, Kai-Hua
    Liu, Zhi-Li
    Sun, Ming
    De, Wei
    Wang, Zhao-Xia
    BMC CANCER, 2012, 12
  • [2] Polo-like kinase-1 as a biomarker in resected non-small cell lung cancer
    O'Leary, C.
    Monkman, J.
    Kirkby, B.
    Matigian, N.
    Kulasinghe, A.
    McCaffrey, E.
    Richard, D.
    Adams, M.
    O'Byrne, K.
    ANNALS OF ONCOLOGY, 2021, 32 : S1224 - S1224
  • [3] microRNA-100 functions as a tumor suppressor in non-small cell lung cancer via regulating epithelial-mesenchymal transition and Wnt/β-catenin by targeting HOXA1
    Han, Weizhong
    Ren, Xiaoxia
    Yang, Yupeng
    Li, Haixia
    Zhao, Lin
    Lin, Zhaoxia
    THORACIC CANCER, 2020, 11 (06) : 1679 - 1688
  • [4] Targeting polo-like kinase 1 and TRAIL to enhance apoptosis in non-small cell lung cancer (NSCLC) cells.
    Noor, Alfiah
    Umelo, Ijeoma Adaku
    Kronenberger, Peter
    Teugels, Erik
    De Greve, Jacques
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [5] Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer
    Georg Wolf
    Robert Elez
    Andreas Doermer
    Uwe Holtrich
    Hanns Ackermann
    Hans Jochen Stutte
    Hans-Michael Altmannsberger
    Helga Rübsamen-Waigmann
    Klaus Strebhardt
    Oncogene, 1997, 14 : 543 - 549
  • [6] Potential Tumor Suppressor Role of Polo-like Kinase 5 in Cancer
    Su, Shengqin
    Ndiaye, Mary Ann
    Guzman-Perez, Glorimar
    Baus, Rebecca Michael
    Huang, Wei
    Patankar, Manish Suresh
    Ahmad, Nihal
    CANCERS, 2023, 15 (22)
  • [7] Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer
    Wolf, G
    Elez, R
    Doermer, A
    Holtrich, U
    Ackermann, H
    Stutte, HJ
    Altmannsberger, HM
    RubsamenWaigmann, H
    Strebhardt, K
    ONCOGENE, 1997, 14 (05) : 543 - 549
  • [8] Polo-like kinase-1 regulation by cyclooxygenase-2 in non-small cell lung cancer
    Kim, Young Whan
    Lee, Kyu-Hwa
    Yim, Jae-Jun
    Yoo, Chul-Gyu
    Lee, Choon-Taek
    Han, Sung Goo
    Shim, Young-Soo
    Sharma, Sherven
    Dubinett, Steven M.
    Yang, Seok-Chul
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (06) : S241 - S241
  • [9] Overexpression of polo-like kinase 1 and its clinical significance in human non-small cell lung cancer
    Wang, Zhao-Xia
    Xue, Dong
    Liu, Zhi-Li
    Lu, Bin-Bin
    Bian, Hai-Bo
    Pan, Xuan
    Yin, Yong-Mei
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2012, 44 (01): : 200 - 210
  • [10] New perspectives on the use of polo-like kinase 1 as a prognostic biomarker in non-small cell lung cancer
    Van den Bossche, Jolien
    Lardon, Filip
    Hermans, Christophe
    Deben, Christophe
    Deschoolmeester, Vanessa
    Jacobs, Julie
    van der Ven, Karlijn
    Del-Favero, Jurgen
    Pauwels, Patrick
    Peeters, Marc
    Wouters, An
    CANCER RESEARCH, 2015, 75
12345